🇰🇷 South Korea Country × Condition
radioembolization Clinical Trials in South Korea
Active clinical trials for radioembolization with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT06773845 Phase 2
Recruiting
Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria
Enrollment
100 pts
Country
🇰🇷 South Korea
Seoul National University Hospital
View Trial → NCT07476651
Recruiting
Scout Dose of Resin Microspheres
Enrollment
30 pts
Country
🇰🇷 South Korea
Seoul National University Hospital
View Trial → Frequently Asked Questions
How many radioembolization clinical trials are active in South Korea?
There are currently 2 active clinical trials for radioembolization with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a radioembolization clinical trial in South Korea?
To join a radioembolization clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are radioembolization trials in South Korea?
Active radioembolization trials in South Korea span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology